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Abstract
It remains largely unknown which factors determine the clinical outcome of human metapneumovirus (HMPV) infections. The aim of
the present study was to analyse whether exposure to bacterial pathogens can inﬂuence HMPV infections. From 57 children, serum
samples and colonization data for Haemophilus inﬂuenzae, Moraxella catarrhalis, Staphylococcus aureus and Streptococcus pneumoniae were
collected at 1.5, 6, 14 and 24 months of age. Seroconversion rates to HMPV were determined and related to bacterial carriage. Fre-
quent nasopharyngeal carriage (‡2 times in the ﬁrst 2 years of life) of S. pneumoniae, but not of the other three pathogens, was associ-
ated with increased seroconversion rates of infants to HMPV at the age of 2 years (frequently vs. less exposed, 93% vs. 59%; p <0.05).
Subsequently, the susceptibility of well-differentiated normal human bronchial epithelial cells (wd-NHBE) pre-incubated with bacterial
pathogens to in vitro HMPV infection was evaluated. Pre-incubation of wd-NHBE with S. pneumoniae resulted in increased susceptibility
to infection with HMPV-enhanced green ﬂuorescent protein (EGFP), as determined by enumeration of EGFP-positive cells. This was not
the case for cells pre-incubated with H. inﬂuenzae, M. catarrhalis on S. aureus. We conclude that exposure to S. pneumoniae can modu-
late HMPV infection.
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Introduction
Acute respiratory tract infections (RTI) caused by bacterial
or viral infections are responsible for considerable morbidity.
Human metapneumovirus (HMPV), a member of the family
Paramyxoviridae, is an important viral cause of RTI [1]. HMPV
causes worldwide seasonal outbreaks of respiratory tract
infections, in moderate climate zones predominantly during
the winter season. The main risk groups for development of
severe disease after HMPV infection are young infants, indi-
viduals with underlying disease and the elderly [2]. In patients
with severe disease the main clinical diagnoses are bronchio-
litis and pneumonia, occasionally leading to death [3].
In young infants HMPV infection appears to be ubiquitous,
as virtually all children are seropositive by the age of 5 years.
Estimates of the percentage of acute paediatric lower RTI
associated with HMPV range from 5% to 25% [2]. However,
it remains largely unknown which factors determine the clini-
cal outcome of HMPV infections. It has been speculated that
disease severity could be enhanced by bacterial superinfec-
tions. Indeed, bacterial pathogens such as Streptococcus
pneumoniae can often be detected in patients with
ª2011 The Authors
Clinical Microbiology and Infection ª2011 European Society of Clinical Microbiology and Infectious Diseases
ORIGINAL ARTICLE INFECTIOUS DISEASES
HMPV-associated severe disease [4]. In addition, the inci-
dence of invasive pneumococcal disease in children is associ-
ated with the seasonality of respiratory virus infections [5].
Furthermore, introduction of a multivalent pneumococcal
conjugate vaccine resulted in reduction of pneumonias asso-
ciated with respiratory virus infections [6]. In mice, HMPV
infection was shown to inﬂuence subsequent superinfection
with S. pneumoniae [7]. The aim of the present study was to
analyse whether exposure to respiratory bacteria can inﬂu-
ence HMPV infections.
Methods
Patients and samples
The study population consisted of 57 healthy children of
the Generation R Focus Study [8]. Enrolled mothers were
residents in the study area at their delivery date, which had
to be between April 2002 and January 2006. Selection of
eligible children for the present study was performed on
the basis of availability of adequate quantities of both nasal
swab samples for bacterial culture and serial serum samples
for assessment of HMPV seroconversion. Samples were
collected after written informed consent from parents or
guardians. The study was carried out in accordance with
human experimentation guidelines in the Netherlands, and
approved by the medical ethical committee of the Erasmus
MC.
For all 57 children, three or four serial serum samples
had been collected over a period of 2 years: 54 (95%) cord
blood serum samples and 32 (56%), 46 (81%) and 45 (79%)
serum samples collected at the ages of 6, 14 and 24 months
of age, respectively. A nasopharyngeal swab was obtained
for cultivation of Haemophilus inﬂuenzae, Moraxella catarrhalis
and S. pneumoniae and a nasal swab was obtained for culti-
vation of Staphylococcus aureus. Bacterial colonization data
were collected at 1.5, 6, 14 and 24 months of age for 40
(70%), 49 (86%), 50 (88%) and 48 (84%) children, respec-
tively. Children were classiﬁed as ‘frequently exposed’ if
two or more swab cultures were positive for one of the
bacterial species in the ﬁrst 2 years of life. When a culture
time-point was missing, this was considered negative. None
of the patients had used antibiotics in the 48 h before swab
collection. Microbiological analyses were performed as
described previously [9]. All children were fully vaccinated
according to the Dutch National Immunization Programme,
including a vaccination with measles-mumps-rubella (MMR)
around the age of 14 months. At the time this study was
performed, vaccination for S. pneumoniae was not part of
the National Immunization Programme.
Serology
Serum IgG levels speciﬁc for HMPV and measles virus (MV)
were quantiﬁed using ELISA as described previously [10].
Brieﬂy, 96-well plates were coated with inactivated MV or
the recombinant fusion protein of HMPV. Serum samples
were tested in duplicate in a 1 : 300 dilution; results are
shown as mean OD-values after subtraction of background
values. A greater than two-fold increase in OD450 resulting
in a value above 0.5 was deﬁned as seroconversion.
Human bronchial epithelial cells
Normal human bronchial epithelial cells (NHBE) were
obtained from Clonetics (Basel, Switzerland) and used at
passage 3–4. Undifferentiated NHBE cells were grown on
30 mg/L type I collagen-coated and 10 mg/L ﬁbronectin-
coated 75-cm2 ﬂasks in serum-free bronchial epithelial cell
basal medium supplemented with BEBM SingleQuots (Clo-
netics). At 60–80% conﬂuency, cells were trypsinized and
seeded at a cell density of 1 · 104 viable cells onto type I
collagen- and ﬁbronectin-coated 6.5-mm transwell inserts
with 0.4-lm pore size (Corning, Amsterdam, The Nether-
lands) in a 50 : 50 mixture of complete BEBM and Dul-
becco’s Modiﬁed Eagle Medium supplemented with 15 ng/
mL retinoic acid. The medium was refreshed every other
day until cells reached conﬂuency, then an air-liquid inter-
face (ALI) was created by removing medium from the apical
side to promote mucociliary differentiation. The medium
was refreshed basolaterally and the apical side was washed
with Dulbecco’s phosphate buffered saline (DPBS, Lonza,
Basel, Switzerland) at 37C every other day. Well-differenti-
ated (wd-) NHBE cells were used for HMPV infection
21 days after ALI, at which stage beating cilia and mucus
production were clearly detectable.
Haemophilus inﬂuenzae (ATCC 49247), M. catarrhalis
(ATCC 25240), S. aureus (ATCC 25923) and S. pneumoniae
(ATCC 49619) were grown twice to log phase on two consec-
utive days on blood agar plates (H. inﬂuenzae on chocolate
plates). Prior to assays, bacteria were washed two times in
antibiotic-free medium. Bacterial numbers were determined
by optical density at 600 nm. Recombinant HMPV encoding
enhanced green ﬂuorescent protein (EGFP) isolate NL/1/00,
further referred to as HMPV-EGFP, was grown as described
previously [11] and had a titre of 6.3 · 106 TCID50/mL. A
recombinant HMPV strain encoding EGFP was used to enable
assessment of numbers of infected cells in real-time (i.e. with-
out ﬁxation and immunoﬂuorescent staining).
wd-NHBE cells were washed with DPBS preceding incuba-
tion with 50 lL of one of the four different species of bacte-
ria (1.5 · 106 bacteria/mL) for 1 h. After incubation with
bacteria, HMPV-EGFP was added (multiplicity of infection
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approximately 10, based on an estimated number of 25 000
wd-NHBE cells exposed to the apical surface). Finally, after
1 h incubation with virus, cells were washed twice with
DPBS. EGFP-positive cells were counted visually at 24 and
48 h post-infection (h.p.i.).This experiment was performed at
least three times using quadruple measurements for each
condition.
Statistical analysis
Statistical analyses were performed with SPSS version 15.0.
The Fisher’s exact test was used for dichotomous outcomes.
Mann–Whitney U-tests were used to compare differences
between mock-treated and bacteria-exposed wd-NHBE cells.
p £0.05 was considered statistically signiﬁcant.
Results
Dynamics of IgG antibody levels
Seroconversion to HMPV and MV was measured in healthy
children during the ﬁrst 2 years of life. In cord blood sam-
ples, high maternal antibody levels speciﬁc for both viruses
could be detected, which gradually declined during the ﬁrst
6 months of life as expected (Fig. 1a, b). All children were
vaccinated with a measles-containing vaccine around the age
of 14 months, which resulted in seroconversion in all infants
at 24 months of age (Fig. 1a). This indicated that all children
were immune-competent. At the age of 14 months 18/46
(39%) and at 24 months 29/45 (64%) of the infants had sero-
converted to HMPV (Fig. 1b).
Relationship between bacterial colonization and HMPV
serology
HMPV seroconversion levels in children frequently exposed
to one of the bacterial species (swab culture 2–4 times posi-
tive) were compared with those in less frequently exposed
children (swab culture 0–1 time positive). Of the total num-
ber of children (n = 57), we only had combined seroconver-
sion bacterial exposure data available for 52 children, and
thus we limited our statistical analysis to this group. There
was no signiﬁcant association between HMPV seroconversion
and exposure to H. inﬂuenzae, M. catarrhalis or S. aureus
(Table 1, p >0.05). However, 14 out of 15 (93%) children
frequently exposed to S. pneumoniae had seroconverted to
HMPV at 24 months, vs. 22 of 37 (59%) less exposed chil-
dren (Table 1, p <0.05). In children who remained seronega-
tive for HMPV during the ﬁrst 2 years of life, only 1 of 16
(7%) was frequently exposed to S. pneumoniae. We conclude
that children frequently exposed to S. pneumoniae mounted a
stronger humoral immune response to the virus.
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FIG. 1. (a, b) Measles virus (MV)-speciﬁc or human metapneumovirus
(HMPV)-speciﬁc IgG levels in sera of healthy infants collected during
the ﬁrst 2 years of life. Black symbols represent S. pneumoniae fre-
quently-exposed children (at least two positive nasal swabs during the
2-year study period), white symbols represent infants less exposed to
S. pneumonia. (c) Well-differentiated normal human bronchial epithelial
(NHBE) cells were incubated with H. inﬂuenzae, M. catarrhalis, S. aur-
eus or S. pneumoniae (or medium as a control) and subsequently
infected with recombinant HMPV encoding enhanced green ﬂuores-
cent protein (EGFP). Data are plotted as means ± standard deviation
of quadruplicate cultures. The experiment was repeated three times.
Signiﬁcant enhancement of HMPV-EGFP infection was seen in wd-
NHBE cells pre-incubated with S. pneumoniae but not in wd-NHBE
cells pre-incubated with any of the other bacterial species.
h.p.i. = hours post-infection. p <0.05 (Mann-Whitney U-test)
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S. pneumoniae enhances HMPV infection of normal human
bronchial epithelial cells
The observations from the cohort study suggest that exposure
to S. pneumoniae was associated with seroconversion to
HMPV, which provides no evidence for a direct interaction
between S. pneumoniae and HMPV infections. To test the
hypothesis that bacterial exposure could enhance susceptibility
to HMPV infection, we used NHBE cells differentiated at the
air-liquid interface. Epithelial cells pre-incubated with S. pneu-
moniae were signiﬁcantly more susceptible to infection with
HMPV-EGFP than mock-treated cells, as evidenced by the enu-
meration of EGFP-positive epithelial cells 24 and 48 h.p.i.
(Fig. 1c, p <0.05; data shown for 24 h.p.i.). This was not the
case for cells pre-incubated with H. inﬂuenzae, M. catarrhalis or
S. aureus (Fig. 1c, p >0.05; data shown for 24 h.p.i.).
Discussion
Interactions between viral and bacterial disease are usually
interpreted as virus infections predisposing for severe bacte-
rial infections [7,12]. Different mechanisms have been pro-
posed, including virus-induced damage to respiratory cells
predisposing to opportunistic bacterial infection or up-regula-
tion of bacterial adhesion molecules by viral infection [13–
15]. The aim of the present study was to analyse whether
bacterial exposure can inﬂuence susceptibility to HMPV
infection. First, we demonstrated for 57 healthy children that
they were immune-competent; indeed, all children had sero-
converted to MV at the age of 24 months, approximately half
a year after MMR vaccination. Subsequently, we screened the
colonization state of these 57 children for four common
respiratory bacterial species (H. inﬂuenzae, M. catarrhalis,
S. aureus and S. pneumoniae) in relation to seroconversion to
HMPV during the ﬁrst 2 years of life. Whereas no relation-
ship was detected between exposure to H. inﬂuenzae, M. ca-
tarrhalis or S. aureus and HMPV seroconversion,
S. pneumoniae exposure was signiﬁcantly associated with
increased seroconversion levels to HMPV. These increased
HMPV seroconversion levels could be due to increased sus-
ceptibility to HMPV infection, increased viral replication or
virus spread, or enhanced immune responses to infection.
Differences in bacterial exposure and HMPV seroconver-
sion could also be related to a common external factor (e.g.
attendance at a day-care centre). However, in that case we
would expect that the carrier state of H. inﬂuenzae, M. ca-
tarrhalis, S. aureus and S. pneumoniae would also be affected.
On the basis of the serology data, we concluded that either
HMPV infection leads to more frequent S. pneumoniae car-
riage or exposure to S. pneumoniae increases the susceptibil-
ity to HMPV infections.
To test our hypothesis that bacterial exposure could
increase the susceptibility to HMPV infection, we used wd-
NHBE cells cultured on the air-liquid interface. The cells
clearly showed beating cilia and mucus production, and may
therefore be considered the best possible in vitro mimic of the
target cells of HMPV infection in vivo. Surprisingly, apical infec-
tion of wd-NHBE cells with HMPV-EGFP at an estimated MOI
of 10 resulted in a low frequency (<1%) of EGFP-expressing
cells 1–2 days after infection. Apparently, apical HMPV infec-
tion of wd-NHBE cells is a relatively inefﬁcient process. How-
ever, pre-incubation of the wd-NHBE cells with S. pneumoniae
resulted in increased susceptibility to HMPV infection as com-
pared with mock controls, as evidenced by more than ten
times higher numbers of infected cells (Fig. 1c).
Several mechanisms could contribute to the observed
increased seroconversion levels in children, or the increased
numbers of in vitro infected wd-NHBE cells, after exposure
to S. pneumoniae. Pneumococcal virulence and immune eva-
sive factors, including capsule or pneumolysin, may facilitate
HMPV infection in multiple ways. First, these factors may
penetrate the mucus layer and inhibit ciliary beating of respi-
ratory epithelial cells [16]. This could expose susceptible
human epithelial cells, resulting in enhancement of HMPV
infection or spread. In addition, HMPV infection may be facil-
itated by inﬂux or activation of immune cells (neutrophils,
lymphocytes or dendritic cells) residing in or associated with
the respiratory epithelium [16]. Moreover, bacterial factors
stimulating TLR2 and TLR4 responses may provoke an
enhanced immune response following HMPV infection. Fur-
thermore, lipopeptides in the bacterial cell wall may lead to
enhanced viral binding to target cells [17], facilitating HMPV
infection and spread. In addition, pneumococcal immune
TABLE 1. Association between frequency of bacterial expo-
sure and human metapneumovirus (HMPV) seroconversion
during early life
Bacterial
pathogen
Frequent
exposurea
HMPV seroconversion
No: n = 16
(31%)
Yes: n = 36
(69%)
H. inﬂuenzae No: n = 42 (81%) 14 (33%)b 28 (67%)
Yes: n = 10 (19%) 2 (20%) 8 (80%)
M. catarrhalis No: n = 41 (79%) 13 (32%) 28 (68%)
Yes: n = 11 (21%) 3 (27%) 8 (73%)
S. aureus No: n = 45 (87%) 14 (31%) 31 (69%)
Yes: n = 7 (13%) 2 (29%) 5 (71%)
S. pneumoniae No: n = 37 (71%) 15 (41%) 22 (59%)
Yes: n = 15 (29%) 1 (7%) 14 (93%)*
aFrequent exposure is deﬁned as at least two positive nasal or nasopharyngeal
swabs during the 2-year study period.
bData are shown as the number of children, followed by the percentage of
those who were or were not frequently exposed between brackets.
*p <0.05 (Fisher’s exact test).
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evasive factors counteract host innate immune responses,
which may also facilitate HMPV infection.
In conclusion, our combined in vivo and in vitro data sug-
gest a speciﬁc interaction between S. pneumoniae and HMPV
infection.
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